Target Audience
This activity is intended for:
Primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the range of current HIV prevention and treatment options.
- Demonstrate approaches to assessing patient preferences and needs through sexual health history-taking.
- Identify appropriate HIV interventions for patients of various ages and demographics, including youth.
- Integrate STI prevention strategies, such as DoxyPEP, into HIV prevention planning based on exposure risk and clinical guidance.
Accreditation, Credit, and Support
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Media: Enduring Material
-
Release date: June 16, 2025
-
Expiration date: June 16, 2026
-
Time to Complete: 45 minutes
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credit. Approval is valid until June 16, 2026.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded .75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for .75 contact hour (0. 075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
UAN JA4008396-0000-25-014-H02-P
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosure
Asia Sullivan, PA-C, MPH
Senior Physician Assistant Dr V Medical, Los Angeles
- Asia Sullivan serves as a speaker on a Speakers Bureau for GlaxoSmithKline (GSK).
- Asia Sullivan has received compensation for social media collaborations with the following commercial interests: Johnson & Johnson, GSK, LabCorp, GoodRx, and Novavax.
All relevant financial relationships have been mitigated in accordance with ACCME and Joint Accreditation standards for integrity and independence in accredited continuing education.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
Target Audience
This activity is intended for:
Primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Educational Objectives
After completing this activity, the participant should be better able to:
- Recognize the impact of stigma, mistrust, and systemic healthcare barriers on LGBTQ individuals.
- Identify evidence-based approaches to improve access, such as navigation support and inclusive care practices.
- Discuss structural barriers—including documentation, insurance, and provider bias—and strategies to address them.
Accreditation, Credit, and Support
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Media: Enduring Material
-
Release date: July 2, 2025
-
Expiration date: July 2, 2026
-
Time to Complete: 45 minutes
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credit. Approval is valid until July 2, 2026.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded .75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for .75 contact hour (0. 075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
UAN JA4008396-0000-25-015-H02-P
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosure
Hyman Scott, MD, MPH
Has no relevant financial relationships with any ineligible companies.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
Target Audience
This activity is intended for:
Primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Content Overview
Engaging Same-Gender-Loving Black and Latino Men in HIV Prevention and Care
Faculty: Orlando Harris, PhD, FNP, MPH
Educational Objectives:
- Describe the rationale for prioritizing same-gender-loving Black and Latino men in HIV prevention and care.
- Identify key social determinants of health affecting HIV prevention and care in same-gender-loving Black and Latino men.
- Evaluate the effectiveness of culturally grounded and community-led care models on HIV prevention and treatment among same-gender-loving Black and Latino men.
- Describe the implications of underrepresentation in HIV clinical trials for same-gender-loving Black and Latino men.
Accreditation, Credit, and Support
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Media: Enduring Material
-
Release date: July 16, 2025
-
Expiration date: July 16, 2026
-
Time to Complete: 45 minutes
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credit. Approval is valid until July 16, 2026.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded .75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for .75 contact hour (0. 075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
UAN JA4008396-0000-25-017-H02-P
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosure
Orlando Harris, PhD, FNP, MPH
Has no relevant financial relationships with any ineligible company
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
Target Audience
This activity is intended for:
Primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Content Overview
Providing Optimal HIV Care to Transgender and Gender Diverse Persons
Faculty: Asa Radix, MD, PhD, MPH
Educational Objectives:
- Identify core epidemiologic and clinical considerations relevant to transgender and gender diverse non-conforming patients.
- Apply strategies for inclusive and affirming HIV care environments.
- Recognize the impact of gender-affirming care in facilitating HIV engagement.
Accreditation, Credit, and Support
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Media: Enduring Material
-
Release date: August 8, 2025
-
Expiration date: August 8, 2026
-
Time to Complete: 45 minutes
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credit. Approval is valid until August 8, 2026.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded .75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for .75 contact hour (0. 075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
UAN JA4008396-0000-25-019-H02-P
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosure
Asa Radix, MD, PhD, MPH
Has no relevant financial relationships with any ineligible company
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
Target Audience
This activity is intended for:
Primary care providers, HIV care providers, LGBTQ health providers, general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and patients/caregivers.
Content Overview
Addressing the Care Needs of Older Gay and Bisexual Men
Faculty: Aniruddha Hazra, MD
Educational Objectives:
- Recognize aging-related health and social challenges in older LGBTQ adults.
- Apply strategies for integrated and geriatric-informed HIV care.
- Address social isolation, mental health, and long-term prevention needs.
Accreditation, Credit, and Support
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Media: Enduring Material
-
Release date: August 15, 2025
-
Expiration date: August 15, 2026
-
Time to Complete: 45 minutes
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credit. Approval is valid until August 15, 2026.
PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded .75 contact hour.
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for .75 contact hour (0. 075 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN number assigned to this activity:
UAN JA4008396-0000-25-018-H02-P
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosure
Aniruddha Hazra, MD has the following relevant financial relationships:
Serves or has served as an advisor, consultant, or independent contractor to:
Gilead Sciences and ViiV Healthcare
Has received research support (as a principal or named investigator) from:
Gilead Sciences
All relevant financial relationships have been mitigated in accordance with the standards of ACCME and Joint Accreditation for Interprofessional Continuing Education.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
Activity Description
The LGBTQ Equity in HIV Prevention and Treatment Series is an online, self-paced CME accredited program composed of five, 45-minute modules addressing strategies to reduce HIV disparities among LGBTQ populations.
Content focuses on overcoming systemic barriers that persist in health access, such as literacy and education gaps, language justice, systemic discrimination, and healthcare misinformation or distrust. By highlighting these barriers and emphasizing an equity focus, the series aims to improve access to HIV prevention and treatment options among LGBTQ persons — especially those who are historically and routinely affected by the syndemics of ongoing and emerging epidemics, such as gay/bisexual Black and Latino men and transgender persons.Target Audience
This activity is intended for licensed social workers at all levels of practice.
Educational Objectives
After completing this activity, the participant should be better able to:
- Increase knowledge of how intersectionality of sexual orientation, gender identity, race/ethnicity and HIV status impacts stigma in healthcare.
- Integrate culturally-sensitive strategies for engaging same- gender-loving Black and Latino men in HIV prevention and care.
- Identify key considerations for providing HIV care to transgender women.
- Implement individualized strategies to improve access to HIV prevention and treatment services among LGBTQ persons.
Program Agenda
|
Individualizing HIV Prevention and Treatment for LGBTQ Persons |
|
|
Accessing HIV Prevention and Care Services Among LGBTQ Persons |
|
|
Engaging Same-Gender-Loving Black and Latino Men in HIV Prevention and Care |
|
|
Providing Optimal HIV Care to Transgender and Gender Non-Conforming Persons |
|
|
Addressing the Care Needs of Older Gay and Bisexual Men |
Accreditation, Credit, and Support
In support of improving patient care, HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Media: Enduring Material
-
Release date: August 22, 2025
-
Expiration date: August 22, 2026
-
Time to Complete: 45 minutes per module
All modules are certified and participants can earn up to 3.75 CEUs (ASWB) for completion of all program components. To receive CE credit, social workers must complete all required components of the activity including: all five (5) modules, the pre-test, post-test, and the final evaluation.
Partial credit is not available.
Social Worker Continuing Education
Social workers completing this course receive up to 3.75 general continuing education.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosure
Please check individual modules for faculty disclosure statements.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 80% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources.
If you have any questions related to educational credits, including the type or amount of credit awarded, reporting of credits to certifying boards, or general accreditation-related inquiries, please contact the Accreditation Team at accreditation@healthhiv.org. A member of our team will be happy to assist you.
If you are experiencing issues accessing or downloading you